CHICAGO (Reuters) - The U.S. government awarded $60 million to researchers and companies on Thursday to develop vaccine adjuvants -- substances designed to boost the immune response and can help stretch short vaccine supplies.
Reuters: U.S., Reuters: Nation
Thu, 10/08/2009 - 9:49am
CHICAGO (Reuters) - The U.S. government awarded $60 million to researchers and companies on Thursday to develop vaccine adjuvants -- substances designed to boost the immune response and can help stretch short vaccine supplies.